Cargando…
Are localized prostate cancer biomarkers useful in the clinical practice?
Prostate cancer presents itself in a heterogeneous way with both aggressive and indolent forms. Despite the controversy surrounding its use, prostate-specific antigen screening ultimately leads to a greater number of diagnosed patients. One of the biggest challenges in clinical practice is to select...
Autores principales: | Carneiro, Arie, Kayano, Paulo Priante, Gomes Barbosa, Álan Roger, Wroclawski, Marcelo Langer, Ko Chen, Carolina, Cavlini, Giulio Costa, Reche, Guilherme Jose, Sanchez-Salas, Rafael, Tobias-Machado, Marcos, Sowalsky, Adam G, Bianco, Bianca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602068/ https://www.ncbi.nlm.nih.gov/pubmed/30204063 http://dx.doi.org/10.1177/1010428318799255 |
Ejemplares similares
-
The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature
por: Carneiro, Arie, et al.
Publicado: (2018) -
Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil
por: Wroclawski, Marcelo Langer, et al.
Publicado: (2022) -
Should aspirin be suspended prior to robot-assisted radical prostatectomy? A systematic review and meta-analysis
por: Carneiro, Arie, et al.
Publicado: (2019) -
Impact of COVID-19 pandemic on prostate cancer outcomes at an uro-oncology referral center
por: Andrade, Guilherme Miranda, et al.
Publicado: (2023) -
Robot-Assisted Nephropexy
por: Wroclawski, Marcelo Langer, et al.
Publicado: (2018)